Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Symptom C0022354|obstructive jaundice
Sentences 10
PubMedID- 19659667 hepatocellular carcinoma (hcc) presenting with obstructive jaundice due to bile duct tumour thrombi is classified as icteric-type hepatoma.
PubMedID- 23788987 Bile duct tumor thrombus (bdtt) is a major cause of hepatocellular carcinoma complicated with obstructive jaundice, and its incidence is 1.2% to 9.0% according to the literature .
PubMedID- 26501145 Clinical data of a total of 200 patients operated from july 2009 to june 2010 at zhongshan hospital, fudan university for pathologically confirmed hepatocellular carcinoma were collected, with those with obstructive jaundice, biliary disease, hepatitis c and alcoholic cirrhosis and incomplete data being excluded.
PubMedID- 23232636 Background: for palliative treatment of the obstructive jaundice associated with unresectable hepatocellular carcinoma (hcc), percutaneous transhepatic biliary drainage (ptbd) or endoscopic retrograde biliary drainage (erbd) has been performed.
PubMedID- 23888306 Background: nonsurgical biliary drainage is considered as a priority for obstructive jaundice associated with unresectable hepatocellular carcinoma (hcc).
PubMedID- 25161794 hepatocellular carcinoma presenting with obstructive jaundice during pregnancy.
PubMedID- 25071072 Background/aims: we investigated the treatment outcomes and prognostic factors of hepatocellular carcinoma (hcc) with obstructive jaundice.
PubMedID- 25048484 Purpose: obstructive jaundice in patients with hepatocellular carcinoma (hcc) is uncommon (0.5-13%).
PubMedID- 21814761 Introduction: obstructive jaundice due to hepatocellular carcinoma is rare.
PubMedID- 23258100 hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.

Page: 1